Todd Christopher Longsworth - Net Worth and Insider Trading

Todd Christopher Longsworth Net Worth

The estimated net worth of Todd Christopher Longsworth is at least $1 Million dollars as of 2025-07-15. Todd Christopher Longsworth is the General Counsel of NovoCure Ltd and owns about 62,462 shares of NovoCure Ltd (NVCR) stock worth over $1 Million. Details can be seen in Todd Christopher Longsworth's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Todd Christopher Longsworth has not made any transactions after 2022-03-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Todd Christopher Longsworth

Todd Christopher Longsworth Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Todd Christopher Longsworth owns 1 companies in total, including NovoCure Ltd (NVCR) .

Click here to see the complete history of Todd Christopher Longsworth’s form 4 insider trades.

Insider Ownership Summary of Todd Christopher Longsworth

Ticker	Company	Transaction Date	Type of Owner
NVCR	NovoCure Ltd	2022-03-08	General Counsel

Todd Christopher Longsworth Latest Holdings Summary

Todd Christopher Longsworth currently owns a total of 1 stock. Todd Christopher Longsworth owns 62,462 shares of NovoCure Ltd (NVCR) as of March 8, 2022, with a value of $1 Million.

Latest Holdings of Todd Christopher Longsworth

Ticker	Company	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
NVCR	NovoCure Ltd	2022-03-08	62,462	17.42	1,088,088

Holding Weightings of Todd Christopher Longsworth

Todd Christopher Longsworth Form 4 Trading Tracker

According to the SEC Form 4 filings, Todd Christopher Longsworth has made a total of 6 transactions in NovoCure Ltd (NVCR) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in NovoCure Ltd is the sale of 2,339 shares on March 8, 2022, which brought Todd Christopher Longsworth around $163,964.

Insider Trading History of Todd Christopher Longsworth

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Todd Christopher Longsworth Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Todd Christopher Longsworth Ownership Network

Ownership Network List of Todd Christopher Longsworth

No Data

Ownership Network Relation of Todd Christopher Longsworth

Todd Christopher Longsworth Owned Company Details

What does NovoCure Ltd do?

Who are the key executives at NovoCure Ltd?

Todd Christopher Longsworth is the General Counsel of NovoCure Ltd. Other key executives at NovoCure Ltd include President & CNS Cancers US Frank X Leonard , Chief Financial Officer Ashley Cordova , and Chief Innovation Officer Uri Weinberg .

NovoCure Ltd (NVCR) Insider Trades Summary

Over the past 18 months, Todd Christopher Longsworth made no insider transaction in NovoCure Ltd (NVCR). Other recent insider transactions involving NovoCure Ltd (NVCR) include a net sale of 67,990 shares made by Frank X Leonard , a net sale of 1,982 shares made by , and a net sale of 29,729 shares made by Ashley Cordova .

In summary, during the past 3 months, insiders sold 38,780 shares of NovoCure Ltd (NVCR) in total and bought 0 shares, with a net sale of 38,780 shares. During the past 18 months, 136,304 shares of NovoCure Ltd (NVCR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 136,304 shares.

NovoCure Ltd (NVCR)'s detailed insider trading history can be found in Insider Trading Tracker table.

NovoCure Ltd Insider Transactions

No Available Data

Todd Christopher Longsworth Mailing Address

Above is the net worth, insider trading, and ownership report for Todd Christopher Longsworth. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Todd Christopher Longsworth's mailing address is: Malvern Pa 19355.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.